title: [Corticosteroid for hemangioma in infants and young children].
abstract: 500 infants and young children suffering from hemangioma treated by corticosteroid (Prednisone) are reported. This disorder is most commonly seen in the head and neck (64.2%). Clinically there are 3 types of hemangioma: intradermal (34.1%), subdermal (11.3%), and mixed (51.5%). Our patients were treated with steroid (Prednisone 20-40 mg/QOD at 8 am). All patients were responsive. In 411 evaluated patients, 151 (36.7%) gave CR, 83 (20.1%) gave CR with residual telangiectasis, 172 (41.5%) gave PR, and in 5 patients, the lesion remained or slightly faded. During and within 3 years of treatment, none developed undesirable side effects, though the treatment was protracted to 2 years.
authors.affiliation: Tumor Hospital, Sun Yat-sen University of Medical Sciences, Guangzhou.
authors.forename: G Q
authors.initials: GQ
authors.lastname: Lai
mesh_terms: D002675:Child, Preschool; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008297:Male; D011241:Prednisone / Q000627:therapeutic use*
chemical_list: D011241:Prednisone